www.newswire.ca
ATMA Welcomes Dr. Scott Shannon, MAPS MDMA Phase 3 Principal Investigator, to Expand Its' Clinical Training Expertise in MDMA-Assisted Therapy
/CNW/ - ATMA Journey Centers Inc. ("ATMA"), a Canadian company with a primary focus on advancing psychedelic-assisted therapy, is pleased to announce its...